Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Elizabeth I. Buchbinder"'
Publikováno v:
Cancers, Vol 16, Iss 3, p 501 (2024)
Immune checkpoint inhibitor (ICI) therapy improves outcomes in several cancers. Unfortunately, many patients experience grade 3–4 treatment-related adverse events, including gastrointestinal (GI) toxicities which are common. These GI immune-related
Externí odkaz:
https://doaj.org/article/d33b64371b5b45c7aca256c09a1afb1d
Autor:
Nazli Dizman, Elizabeth I. Buchbinder
Publikováno v:
Cancers, Vol 13, Iss 24, p 6229 (2021)
In the past decade, the field of cancer immunotherapy has rapidly advanced, establishing a crucial role for immune checkpoint blockers in the treatment of a variety of cancer types. In parallel with these remarkable clinical developments, further eff
Externí odkaz:
https://doaj.org/article/7b8ce4f2767b451ab76f224a3515dd52